{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T22:48:03Z","timestamp":1791413283803,"version":"4.3.3"},"reference-count":48,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2013,4,5]],"date-time":"2013-04-05T00:00:00Z","timestamp":1365120000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0060579","type":"journal-article","created":{"date-parts":[[2013,4,5]],"date-time":"2013-04-05T21:21:04Z","timestamp":1365196864000},"page":"e60579","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":235,"title":["A Systematic Screen of FDA-Approved Drugs for Inhibitors of Biological Threat Agents"],"prefix":"10.1371","volume":"8","author":[{"given":"Peter B.","family":"Madrid","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sidharth","family":"Chopra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian D.","family":"Manger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynne","family":"Gilfillan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiffany R.","family":"Keepers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy C.","family":"Shurtleff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol E.","family":"Green","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lalitha V.","family":"Iyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holli Hutcheson","family":"Dilks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Davey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrey A.","family":"Kolokoltsov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo","family":"Carrion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean L.","family":"Patterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sina","family":"Bavari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rekha G.","family":"Panchal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Travis K.","family":"Warren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay B.","family":"Wells","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter H.","family":"Moos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"RaeLyn L.","family":"Burke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary J.","family":"Tanga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2013,4,5]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1089\/bsp.2011.0051","article-title":"Evaluation of perceived threat differences posed by filovirus variants","volume":"9","author":"JH Kuhn","year":"2011","journal-title":"Biosecur Bioterror"},{"key":"ref2","unstructured":"Center for Disease Control and Prevention (2013) Bioterrorism Agents\/Diseases. Center for Disease Control and Prevention. Available: http:\/\/www.bt.cdc.gov\/agent\/agentlist-category.asp<\/ext-link>: Accessed 10 Feb 2013."},{"key":"ref3","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1001\/jama.287.17.2236","article-title":"Anthrax as a biological weapon, 2002: Updated recommendations for management","volume":"287","author":"TV Inglesby","year":"2002","journal-title":"JAMA"},{"key":"ref4","unstructured":"Center for Disease Control and Prevention (2012) Anthrax. Available: http:\/\/emergency.cdc.gov\/agent\/anthrax\/<\/ext-link>: Accessed 29 Feb 2012."},{"key":"ref5","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1128\/CMR.15.4.631-646.2002","article-title":"Tularemia","volume":"15","author":"J Ellis","year":"2002","journal-title":"Clin Microbiol Rev"},{"key":"ref6","unstructured":"Center for Disease Control and Prevention (2012) Tularemia. Available: http:\/\/emergency.cdc.gov\/agent\/tularemia\/<\/ext-link>: Accessed 29 Feb 2012."},{"key":"ref7","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1128\/MMBR.25.3.285-293.1961","article-title":"AIRBORNE Q FEVER","volume":"25","author":"WD Tigertt","year":"1961","journal-title":"Bacteriological Reviews"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S1473-3099(03)00804-1","article-title":"Q fever: a biological weapon in your backyard","volume":"3","author":"MG Madariaga","year":"2003","journal-title":"Lancet Infect Dis"},{"key":"ref9","first-page":"227","article-title":"Lethal experimental infections of rhesus monkeys by aerosolized Ebola virus","volume":"76","author":"E Johnson","year":"1995","journal-title":"Int J Exp Pathol"},{"key":"ref10","unstructured":"Center for Disease Control and Prevention (2012) Viral Hemorrhagic Fevers. Available: http:\/\/www.cdc.gov\/ncidod\/dvrd\/spb\/mnpages\/dispages\/vhf.htm<\/ext-link>: Accessed 29 Feb 2012."},{"key":"ref11","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1111\/j.1365-2125.2007.03058.x","article-title":"Old drugs\u2013new uses","volume":"64","author":"JK Aronson","year":"2007","journal-title":"Br J Clin Pharmacol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/448645a","article-title":"New uses for old drugs","volume":"448","author":"CR Chong","year":"2007","journal-title":"Nature"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/nrd1468","article-title":"Drug repositioning: identifying and developing new uses for existing drugs","volume":"3","author":"TT Ashburn","year":"2004","journal-title":"Nat Rev Drug Discov"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1126\/science.1169920","article-title":"Drug discovery. Repurposing with a difference","volume":"324","author":"MS Boguski","year":"2009","journal-title":"Science"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"11473","DOI":"10.1073\/pnas.0604348103","article-title":"Quantitative high-throughput screening: a titration-based approach that efficiently identifies biological activities in large chemical libraries","volume":"103","author":"J Inglese","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref16","unstructured":"U.S. Food and Drug Administration (2010) Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations. Silver Spring, MD: U.S. FDA."},{"key":"ref17","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/S1473-3099(03)00806-5","article-title":"Effects of chloroquine on viral infections: an old drug against today\u2019s diseases?","volume":"3","author":"A Savarino","year":"2003","journal-title":"Lancet Infect Dis"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S1473-3099(07)70217-7","article-title":"On the use of chloroquine for chikungunya","volume":"7","author":"A Savarino","year":"2007","journal-title":"Lancet Infect Dis"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.ijantimicag.2007.05.015","article-title":"Recycling of chloroquine and its hydroxyl analogue to face bacterial, fungal and viral infections in the 21st century","volume":"30","author":"JM Rolain","year":"2007","journal-title":"Int J Antimicrob Agents"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.virusres.2008.03.014","article-title":"Dehydroepiandrosterone, epiandrosterone and synthetic derivatives inhibit Junin virus replication in vitro","volume":"135","author":"EG Acosta","year":"2008","journal-title":"Virus Res"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"4918","DOI":"10.1021\/jm980146x","article-title":"Structure-activity relationships for antiplasmodial activity among 7-substituted 4-aminoquinolines","volume":"41","author":"D De","year":"1998","journal-title":"J Med Chem"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jviromet.2006.02.011","article-title":"Novel, rapid assay for measuring entry of diverse enveloped viruses, including HIV and rabies","volume":"135","author":"MF Saeed","year":"2006","journal-title":"J Virol Methods"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1743-422X-4-39","article-title":"Different pH requirements are associated with divergent inhibitory effects of chloroquine on human and avian influenza A viruses","volume":"4","author":"L Di Trani","year":"2007","journal-title":"Virol J"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1097\/00002030-200111230-00002","article-title":"Anti-HIV effects of chloroquine: mechanisms of inhibition and spectrum of activity","volume":"15","author":"A Savarino","year":"2001","journal-title":"AIDS"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1097\/00126334-200403010-00002","article-title":"Anti-HIV effects of chloroquine: inhibition of viral particle glycosylation and synergism with protease inhibitors","volume":"35","author":"A Savarino","year":"2004","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"2883","DOI":"10.1128\/JVI.01956-08","article-title":"The primed ebolavirus glycoprotein (19-kilodalton GP1,2): sequence and residues critical for host cell binding","volume":"83","author":"D Dube","year":"2009","journal-title":"J Virol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"8003","DOI":"10.1073\/pnas.0807578106","article-title":"Alpha5beta1-integrin controls ebolavirus entry by regulating endosomal cathepsins","volume":"106","author":"KL Schornberg","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"S237","DOI":"10.1086\/520607","article-title":"Analysis of the interaction of Ebola virus glycoprotein with DC-SIGN (dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin) and its homologue DC-SIGNR","volume":"196","author":"A Marzi","year":"2007","journal-title":"J Infect Dis"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"F1050","DOI":"10.1152\/ajprenal.00461.2007","article-title":"Chloroquine and inhibition of Toll-like receptor 9 protect from sepsis-induced acute kidney injury","volume":"294","author":"H Yasuda","year":"2008","journal-title":"Am J Physiol Renal Physiol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1750-2659.2007.00027.x","article-title":"Chloroquine is effective against influenza A virus in vitro but not in vivo","volume":"1","author":"DJ Vigerust","year":"2007","journal-title":"Influenza Other Respi Viruses"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1099\/vir.0.017269-0","article-title":"Combined chloroquine and ribavirin treatment does not prevent death in a hamster model of Nipah and Hendra virus infection","volume":"91","author":"AN Freiberg","year":"2010","journal-title":"J Gen Virol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"11979","DOI":"10.1128\/JVI.01847-09","article-title":"Chloroquine administration does not prevent Nipah virus infection and disease in ferrets","volume":"83","author":"J Pallister","year":"2009","journal-title":"J Virol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1089\/vbz.2008.0049","article-title":"On chikungunya acute infection and chloroquine treatment","volume":"8","author":"X De Lamballerie","year":"2008","journal-title":"Vector Borne Zoonotic Dis"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2174\/187152609787847712","article-title":"Antiviral treatment of chikungunya virus infection","volume":"9","author":"X De Lamballerie","year":"2009","journal-title":"Infect Disord Drug Targets"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"e785","DOI":"10.1371\/journal.pntd.0000785","article-title":"A randomized controlled trial of chloroquine for the treatment of dengue in Vietnamese adults","volume":"4","author":"V Tricou","year":"2010","journal-title":"PLoS Negl Trop Dis"},{"key":"ref36","first-page":"374","article-title":"Tissue reaction after intramuscular injection of liposomes in mice","volume":"30","author":"F Kadir","year":"1992","journal-title":"Int J Clin Pharmacol Ther Toxicol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/0005-2736(89)90037-0","article-title":"Therapeutic effect of chloroquine(CQ)-containing immunoliposomes in rats infected with Plasmodium berghei parasitized mouse red blood cells: comparison with combinations of antibodies and CQ or liposomal CQ","volume":"981","author":"PA Peeters","year":"1989","journal-title":"Biochim Biophys Acta"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1017\/S003118200006145X","article-title":"Chloroquine containing liposomes in the chemotherapy of murine malaria","volume":"3","author":"PA Peeters","year":"1989","journal-title":"Parasitology 98 Pt"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/j.2042-7158.1990.tb07052.x","article-title":"The parenteral controlled release of liposome encapsulated chloroquine in mice","volume":"42","author":"HA Titulaer","year":"1990","journal-title":"J Pharm Pharmacol"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"113","DOI":"10.2174\/1389557013407188","article-title":"Structure-function relationships in chloroquine and related 4-aminoquinoline antimalarials","volume":"1","author":"TJ Egan","year":"2001","journal-title":"Mini Rev Med Chem"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"4933","DOI":"10.1021\/jm030796n","article-title":"Isoquine and related amodiaquine analogues: a new generation of improved 4-aminoquinoline antimalarials","volume":"46","author":"PM O\u2019Neill","year":"2003","journal-title":"J Med Chem"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"479","DOI":"10.2174\/156802606776743147","article-title":"A medicinal chemistry perspective on 4-aminoquinoline antimalarial drugs","volume":"6","author":"PM O\u2019Neill","year":"2006","journal-title":"Curr Top Med Chem"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1016\/j.bmc.2004.12.051","article-title":"Design and synthesis of new antimalarial agents from 4-aminoquinoline","volume":"13","author":"VR Solomon","year":"2005","journal-title":"Bioorg Med Chem"},{"key":"ref44","unstructured":"National Research Council of the National Academies (2011) Guide for the Care and Use of Laboratory Animals. In: Institute for Laboratory Animal Research, editor. 8th ed. Washington, D.C.: The National Academies Press."},{"key":"ref45","doi-asserted-by":"crossref","first-page":"S248","DOI":"10.1086\/514292","article-title":"A mouse model for evaluation of prophylaxis and therapy of Ebola hemorrhagic fever","volume":"179","author":"M Bray","year":"1999","journal-title":"J Infect Dis"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1177\/1087057110374357","article-title":"Development of high-content imaging assays for lethal viral pathogens","volume":"15","author":"RG Panchal","year":"2010","journal-title":"J Biomol Screen"},{"key":"ref47","unstructured":"Eli Lilly and Company and NIH Chemical Genomics Center (2008) Assay Guidance Manual Version 5.0. Available: http:\/\/www.ncgc.nih.gov\/guidance\/manual_toc.html<\/ext-link>."},{"key":"ref48","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1177\/108705719900400206","article-title":"A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays","volume":"4","author":"J-H Zhang","year":"1999","journal-title":"J Biomol Screen"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0060579","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,25]],"date-time":"2020-07-25T00:25:47Z","timestamp":1595636747000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0060579"}},"subtitle":[],"editor":[{"given":"Xue-jie","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2013,4,5]]},"references-count":48,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2013,4,5]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0060579","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,4,5]]}}}